What are the most important randomized studies that support ECP and what do we still need to know about ECP as a foundational, second-line treatment strategy for GVHD?

What are the most important randomized studies that support ECP and what do we still need to know about ECP as a foundational, second-line treatment strategy for GVHD?

What are the most important randomized studies that support ECP and what do we still need to know about ECP as a foundational, second-line treatment strategy for GVHD?

 


Created by

CMEducation Resources IQ&A Extracorporeal Photopheresis Intelligence Zone | The Multi-Specialty Perspective

Presenter

Daniel Couriel, MD, MS

Daniel Couriel, MD, MS

Daniel R. Couriel, MD, MS
Professor of Internal Medicine
Director, Huntsman Cancer Institute (HCI) Blood and Marrow Transplant Program
University of Utah School of Medicine
Salt Lake City, UT